<VariationArchive VariationID="195306" VariationName="NM_015311.3(OBSL1):c.1273dup (p.Thr425fs)" VariationType="Duplication" Accession="VCV000195306" Version="18" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-07-15" DateCreated="2015-08-07" MostRecentSubmission="2023-10-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="192467" VariationID="195306">
      <GeneList>
        <Gene Symbol="OBSL1" FullName="obscurin like cytoskeletal adaptor 1" GeneID="23363" HGNC_ID="HGNC:29092" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q35</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219547206" stop="219571539" display_start="219547206" display_stop="219571539" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220415449" stop="220436267" display_start="220415449" display_stop="220436267" Strand="-" />
          </Location>
          <OMIM>610991</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015311.3(OBSL1):c.1273dup (p.Thr425fs)</Name>
      <CanonicalSPDI>NC_000002.12:219568063:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q35</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219568063" stop="219568064" display_start="219568063" display_stop="219568064" variantLength="1" positionVCF="219568063" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220432785" stop="220432786" display_start="220432785" display_stop="220432786" variantLength="1" positionVCF="220432785" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <OtherNameList>
        <Name>p.Thr425AsnfsTer40</Name>
      </OtherNameList>
      <ProteinChange>T425fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.220432786dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.220432786dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.219568064dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.219568064dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016977.1" sequenceAccession="NG_016977" sequenceVersion="1" change="g.8483dup">
            <Expression>NG_016977.1:g.8483dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001173408.2" sequenceAccession="NM_001173408" sequenceVersion="2" change="c.1273dup">
            <Expression>NM_001173408.2:c.1273dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166879.1" sequenceAccession="NP_001166879" sequenceVersion="1" change="p.Thr425fs">
            <Expression>NP_001166879.1:p.Thr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001173431.2" sequenceAccession="NM_001173431" sequenceVersion="2" change="c.1273dup">
            <Expression>NM_001173431.2:c.1273dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166902.1" sequenceAccession="NP_001166902" sequenceVersion="1" change="p.Thr425fs">
            <Expression>NP_001166902.1:p.Thr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015311.3" sequenceAccession="NM_015311" sequenceVersion="3" change="c.1273dup" MANESelect="true">
            <Expression>NM_015311.3:c.1273dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056126.1" sequenceAccession="NP_056126" sequenceVersion="1" change="p.Thr425fs">
            <Expression>NP_056126.1:p.Thr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015311.2" sequenceAccession="NM_015311" sequenceVersion="2" change="c.1273dupA">
            <Expression>NM_015311.2:c.1273dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA275079" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610991.0001" DB="OMIM" />
        <XRef Type="rs" ID="762334954" DB="dbSNP" />
        <XRef Type="Interpreted" ID="916539" DB="ClinVar" />
        <XRef Type="Interpreted" ID="998035" DB="ClinVar" />
      </XRefList>
      <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
        <XRef ID="0347" DB="Variation Ontology" />
      </FunctionalConsequence>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00009" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00014" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00015" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00016" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00024" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015311.3(OBSL1):c.1273dup (p.Thr425fs) AND 3M syndrome 2" Accession="RCV000175869" Version="14">
        <ClassifiedConditionList TraitSetID="279">
          <ClassifiedCondition DB="MedGen" ID="C2752041">3M syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015311.3(OBSL1):c.1273dup (p.Thr425fs) AND not provided" Accession="RCV000790703" Version="11">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-01" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-23" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2015-08-07" MostRecentSubmission="2023-10-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Keskin, M. Personal Communication. 2019. Ankara, Turkey</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19481195</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19877176</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25923536</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27796265</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28969986</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="279" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6960" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3M syndrome 2</ElementValue>
                <XRef ID="MONDO:0013039" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Three M syndrome 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">3M2</ElementValue>
                <XRef Type="MIM" ID="612921" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Three M syndrome is characterized by severe pre- and postnatal growth deficiency (final height 5-6 SD below the mean; i.e., 120-130 cm), characteristic facies, and normal intelligence. Additional features of three M syndrome include short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and loose joints. Males with three M syndrome have hypogonadism and occasionally hypospadias.</Attribute>
                <XRef ID="NBK1481" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15591" />
                <XRef ID="15591" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301654</ID>
                <ID Source="BookShelf">NBK1481</ID>
              </Citation>
              <XRef ID="2616" DB="Orphanet" />
              <XRef ID="C2752041" DB="MedGen" />
              <XRef ID="MONDO:0013039" DB="MONDO" />
              <XRef Type="MIM" ID="612921" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="439298" SubmissionDate="2015-07-21" DateLastUpdated="2015-08-07" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="NM_015311.2:c.1273dupA|OMIM:612921" />
        <ClinVarAccession Accession="SCV000238469" DateUpdated="2015-08-07" DateCreated="2015-07-05" Type="SCV" Version="2" SubmitterName="Division of Human Genetics, Children's Hospital of Philadelphia" OrgID="505472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-06-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19481195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19877176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25923536</ID>
          </Citation>
          <Comment Type="public">The OBSL1 variant (c.1273dupA; p.T425fs) is considered pathogenic because it is a frameshift variant predicted to result in a truncated protein containing only one-third of the normal protein. This is a common OBSL1 variant associated with 3-M syndrome reported in 6 families (Huber et al. 2010, PMID 19877176) and 6 families (Hanson et al. 2009, PMID 19481195) mostly in the homozygous state in consanguineous families. This variant is present in 17 alleles out of 121632 alleles in ExAC. Another frameshift variant has been reported downstream of this position</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.2:c.1273dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">3-M syndrome 2</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="612921" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-PediSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>CSER-PediSeq</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="21250" SubmissionDate="2019-01-30" DateLastUpdated="2019-02-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610991.0001_THREE M SYNDROME 2" title="OBSL1, 1-BP INS, 1273A_THREE M SYNDROME 2" />
        <ClinVarAccession Accession="SCV000021250" DateUpdated="2019-02-04" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 4 unrelated families of Asian origin with 3M syndrome-2 (3M2; 612921), Hanson et al. (2009) identified a homozygous 1-bp insertion (1273insA) in exon 3 of the OBSL1 gene, causing a frameshift predicted to result in a premature termination codon (Thr425AsnfsTer40). The mutation occurred near the N terminus and affected all OBSL1 isoforms, consistent with complete loss of protein function and a null phenotype. Two of the families were large consanguineous families with multiple affected individuals. Two additional probands with the disorder were compound heterozygous for the 1273insA mutation and another truncating mutation in the OBSL1 gene: a 1149C-A transversion in exon 3, resulting in a cys383-to-ter substitution (C383X; 610991.0002), and a 10-bp deletion in exon 3 (610991.0003), respectively.</Attribute>
              <Citation>
                <ID Source="PubMed">19481195</ID>
              </Citation>
              <XRef DB="OMIM" ID="612921" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 16-month-old Turkish girl with 3M syndrome, Keskin et al. (2017) identified homozygosity for this mutation, which they designated c.1273dupA, in the OBSL1 gene. Her unaffected consanguineous parents were heterozygous for the mutation. Although Keskin et al. (2017) referred to the effect on the protein in their patient as Thr45AsnfsTer40, and in previously reported patients as Thr245fsTer40, they stated in a personal communication (Keskin, 2019) that Thr425AsnfsTer40 is the correct designation.</Attribute>
              <Citation>
                <CitationText>Keskin, M. Personal Communication. 2019. Ankara, Turkey</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">27796265</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <Name>OBSL1, 1-BP INS, 1273A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1273A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610991.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">THREE M SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="415756" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-30" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="24954_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000227439" DateUpdated="2019-07-30" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19481195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19877176</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="T" referenceAllele="-" start="220432785" stop="220432786" variantLength="2" />
            <GeneLocation>NM_015311.2:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI093475" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=OBSL1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2669201" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_015311.2:c.1273dup|MedGen:C2752041" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001360883" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19481195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28969986</ID>
          </Citation>
          <Comment>Variant summary: OBSL1 c.1273dupA (p.Thr425AsnfsX40) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00016 in 247272 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in OBSL1 causing 3-M syndrome 2 (0.00016 vs 0.0011), allowing no conclusion about variant significance. c.1273dupA has been reported in the literature in multiple homozygous- and compound heterozygous individuals affected with 3-M syndrome 2 (e.g. Hanson_2009, Hu_2017). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and both of them classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.2:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Three M syndrome 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C2752041" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3054745" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr2:220432784-220432785:f2e83d1c8ef0863bcf51a7162ad180e3" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001553568" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The OBSL1 p.Thr425Asnfs*40 variant was identified in 25 of 50 proband chromosomes (frequency: 0.5) from 25 families with Miller-McKusick-Malvaux (3-M) syndrome (Hanson_2009_PMID:19481195; Huber_2010_PMID:19877176; Marshall_2015_PMID:25923536; Keskin_2017_PMID:27796265). The variant was identified in dbSNP (ID: rs762334954) and ClinVar (classifed as pathogenic by EGL Genetics, Division of Human Genetics, Children's Hospital of Philadelphia and OMIM) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 46 of 278660 chromosomes at a frequency of 0.000165 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 36 of 126596 chromosomes (freq: 0.000284), South Asian in 5 of 30580 chromosomes (freq: 0.000164), Latino in 4 of 35350 chromosomes (freq: 0.000113) and African in 1 of 24184 chromosomes (freq: 0.000041), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) or Other populations. The c.1273dup variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 425 and leads to a premature stop codon 40 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the OBSL1 gene are an established mechanism of disease in 3-M syndrome and are known to cause the disorder in the homozygous or compound heterozygous state. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GT" referenceAllele="G" start="220432785" stop="220432785" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3597497" SubmissionDate="2021-09-04" DateLastUpdated="2021-09-10" DateCreated="2021-09-10">
        <ClinVarSubmissionID localKey="20034|OMIM:612921" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001837622" DateUpdated="2021-09-10" DateCreated="2021-09-10" Type="SCV" Version="1" SubmitterName="Suma Genomics" OrgID="508066" OrganizationCategory="laboratory" OrgAbbreviation="Suma" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next Generation Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.3:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612921" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10319532</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7109743" SubmissionDate="2023-02-24" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="SUB12912621" submittedAssembly="GRCh37" title="SUB12912621" />
        <ClinVarAccession Accession="SCV003804426" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Pediatric Endocrinology, Ankara Etlik City Hospital" OrgID="508971" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Molecular analysis of the OBSL1 gene identified a frameshift variant (c.1273dup; p.Thr425fs) in seven patients with clinical features consistent with 3M syndrome, six of whom were in homozygous and one was in compound heterozygous state. This variant results in a premature stop codon leading to truncation of the protein or nonsense mediated decay. Also, loss-of-function variants in OBSL1 gene have been determined to be deleterious. The detected variant has been associated with 3M syndrome in the literature previously. This variant was classified as pathogenic according to the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Turkish</Ethnicity>
              <GeographicOrigin>Turkey</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="months">3</Age>
              <Age Type="maximum" age_unit="months">97</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="6" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1">
              <Name>obscurin like cytoskeletal adaptor 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs762334954" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.3:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612921" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12912621</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7109744" SubmissionDate="2023-02-24" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="SUB12914064" submittedAssembly="GRCh38" title="SUB12914064" />
        <ClinVarAccession Accession="SCV003804434" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous single base pair duplication in exon 2 of the OBSL1 gene that results in a frameshift and premature truncation of the protein 40 amino acids downstream to codon 425 (p.Thr425AsnfsTer40) was detected. The p.Thr425AsnfsTer40 variant has not been reported in the 1000 genomes databases and has a minor allele frequency of 0.01% in the gnomAD database. The in silico predictions of the variant are damaging by MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2023-01-26" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000648" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1">
              <Name>obscurin like cytoskeletal adaptor 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_015311.3:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Thr425AsnfsTer40</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.3:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612921" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12914064</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3516206" SubmissionDate="2022-08-31" DateLastUpdated="2023-03-04" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="GDXSV:237838" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001791852" DateUpdated="2023-03-04" DateCreated="2021-08-21" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 19481195, 25923536, 27796265, 28969986, 29595812, 34597859, 19877176, 34426522, 31589614, 33258289, 33135300, 34006472)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2421866</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.2:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_126_20220831054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_24_20210817091645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7575040" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20100101007" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004048304" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift variant has been reported previously in homozygous state in a patient who presented with prenatal growth retardation and short stature (Keskin M. et al., 2019). This variant is reported with the allele frequency (0.02%) in the gnomad and novel in 1000 genome database. It has been submitted to the ClinVar as a Pathogenic variant. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001510" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002652" />
              </Trait>
              <Comment>Current age: 4 years old male Clinical symptoms: Poor growth Clinical suspicion: Skeletal dysplasia</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015311.3:c.1273dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612921" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5961653" SubmissionDate="2023-01-10" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="2880089|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003272353" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19481195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19877176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19481195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25923536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27796265</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr425Asnfs*40) in the OBSL1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OBSL1 are known to be pathogenic (PMID: 19481195, 19877176). This variant is present in population databases (rs762334954, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with 3-M syndrome (PMID: 19481195, 25923536, 27796265). This variant is also known as c.1273insA, p.T45Nfs*40. ClinVar contains an entry for this variant (Variation ID: 195306). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OBSL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.220432785_220432786insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7575040" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002652" MappingRef="HP">
        <MedGen CUI="C0410528" Name="Skeletal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="415756" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109744" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575040" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001510" MappingRef="HP">
        <MedGen CUI="C0456070" Name="Growth delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21250" TraitType="Disease" MappingType="Name" MappingValue="THREE M SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3597497" TraitType="Disease" MappingType="XRef" MappingValue="612921" MappingRef="OMIM">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575040" TraitType="Disease" MappingType="XRef" MappingValue="612921" MappingRef="OMIM">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2669201" TraitType="Disease" MappingType="Name" MappingValue="Three M syndrome 2" MappingRef="Preferred">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3516206" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="439298" TraitType="Disease" MappingType="Name" MappingValue="3-M syndrome 2" MappingRef="Preferred">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3054745" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109743" TraitType="Disease" MappingType="XRef" MappingValue="612921" MappingRef="OMIM">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5961653" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109744" TraitType="Disease" MappingType="XRef" MappingValue="612921" MappingRef="OMIM">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109743" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7109744" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000648" MappingRef="HP">
        <MedGen CUI="C0029124" Name="Optic atrophy" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528963</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002020568</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

